The present invention relates to a naphthalimidobenzamide derivative represented by the following formula (1):
(wherein, R1 represents a hydrogen atom, etc., Y represents a hydrogen atom or -CON(R4)-A2-X2, R2 and R4 are the same or different and each independently represents a hydrogen atom, etc., A1 and A2 are the same or different and each independently represents an alkylene group which may be interrupted at least once by -N(R3)- (R3 representing a hydrogen atom, etc.) and X1 and X2 are the same or different and each independently represents a (hetero)aryl group which may have a substituent, etc.) or salt thereof; and a pharmaceutical comprising it as an effective ingredient. The compound is useful as an antitumor agent and the like.
本发明涉及由下式(1)代表的
萘亚
氨基苯甲酰胺衍
生物:
(其中,R1代表氢原子等,Y代表氢原子或-CON(R4)-A2-X2,R2和R4相同或不同,各自独立地代表氢原子等、A1和A2相同或不同,各自独立地代表可至少被-N(R3)-中断一次的亚烷基(R3代表氢原子等),X1和X2相同或不同,各自独立地代表可具有取代基的(杂)芳基等)或其盐;以及包含其作为有效成分的药物。该化合物可用作抗肿瘤剂等。